A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...
Untreated human immunodeficiency virus (HIV) infection markedly increases the risk of tuberculosis, which remains the most common cause of hospitalization and death globally among people with HIV ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...
In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in some who had been infected. Importantly, this was when experts still ...
A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...
– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment – – Latest Data from the PURPOSE Program Further Demonstrates the ...
Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) that attacks the body’s immune system, making it vulnerable to all infections. One of the major concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results